Creo Medical Group (CREO)

Sector:

Health Care

Index:

FTSE AIM All-Share

16.13p
   
  • Change Today:
    -0.13p
  • 52 Week High: 48.10
  • 52 Week Low: 15.70
  • Currency: UK Pounds
  • Shares Issued: 412.15m
  • Volume: 519,832
  • Market Cap: £66.46m
  • Beta: 0.28

Creo Medical extends closing date for retail offer

By Josh White

Date: Friday 04 Oct 2024

LONDON (ShareCast) - (Sharecast News) - Creo Medical Group announced an extension to the closing date for its retail offer on Friday, allowing existing retail shareholders more time to participate.
The AIM-traded firm said the new deadline was now set for 1630 BST on 17 October, extended from the previous closing date of 7 October.

It said there were no other changes to the overall timetable, with applications already made still valid and binding.

The revised schedule included key dates such as the receipt of proxy forms and CREST voting instructions by 1000 BST on 16 October, followed by the closing of the retail offer on 17 October.

Creo said the general meeting would take place at 1000 BST on 18 October, with the results of the meeting announced on the same day.

Trading of the new shares on AIM was expected to start on 21 October, with CREST accounts credited and share certificates dispatched by 3 November where applicable.

At 1551 BST, shares in Creo Medical Group were down 2% at 22p.

Reporting by Josh White for Sharecast.com.

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

CREO Market Data

Currency UK Pounds
Share Price 16.13p
Change Today -0.13p
% Change -0.77 %
52 Week High 48.10
52 Week Low 15.70
Volume 519,832
Shares Issued 412.15m
Market Cap £66.46m
Beta 0.28

CREO Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
9.49% above the market average9.49% above the market average9.49% above the market average9.49% above the market average9.49% above the market average
25.71% below the sector average25.71% below the sector average25.71% below the sector average25.71% below the sector average25.71% below the sector average
Price Trend
84.46% below the market average84.46% below the market average84.46% below the market average84.46% below the market average84.46% below the market average
56.76% below the sector average56.76% below the sector average56.76% below the sector average56.76% below the sector average56.76% below the sector average
Income Not Available
Growth
24.41% above the market average24.41% above the market average24.41% above the market average24.41% above the market average24.41% above the market average
55.56% above the sector average55.56% above the sector average55.56% above the sector average55.56% above the sector average55.56% above the sector average

What The Brokers Say

Strong Buy 1
Buy 0
Neutral 0
Sell 0
Strong Sell 0
Total 1
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

CREO Dividends

No dividends found

Trades for 21-Nov-2024

Time Volume / Share Price
16:20 20,343 @ 16.12p
16:10 3,206 @ 16.15p
14:56 234 @ 16.24p
14:45 19,868 @ 16.12p
13:59 38,584 @ 16.12p

CREO Key Personnel

CEO Craig Jonathan Gulliford
CFO Richard John Rees

Top of Page